No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Aprepitant
-
Area Under Curve
-
Cytochrome P-450 CYP3A
-
Cytochrome P-450 CYP3A Inhibitors*
-
Drug Administration Schedule
-
Drug Interactions
-
Erlotinib Hydrochloride
-
Humans
-
Morpholines / administration & dosage*
-
Neurokinin-1 Receptor Antagonists*
-
Off-Label Use
-
Protein Kinase Inhibitors / adverse effects
-
Pruritus / chemically induced
-
Pruritus / drug therapy*
-
Quinazolines / adverse effects
-
Quinazolines / pharmacokinetics*
Substances
-
Antineoplastic Agents
-
Cytochrome P-450 CYP3A Inhibitors
-
Morpholines
-
Neurokinin-1 Receptor Antagonists
-
Protein Kinase Inhibitors
-
Quinazolines
-
Aprepitant
-
Erlotinib Hydrochloride
-
Cytochrome P-450 CYP3A
-
CYP3A4 protein, human